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Abstract
Aims. To investigate the association between parity and the risk of incident dementia in
women.
Methods. We pooled baseline and follow-up data for community-dwelling women aged
60 or older from six population-based, prospective cohort studies from four European
and two Asian countries. We investigated the association between parity and incident
dementia using Cox proportional hazards regression models adjusted for age, educational
level, hypertension, diabetes mellitus and cohort, with additional analysis by dementia
subtype (Alzheimer dementia (AD) and non-Alzheimer dementia (NAD)).
Results. Of 9756 women dementia-free at baseline, 7010 completed one or more follow-up
assessments. The mean follow-up duration was 5.4 ± 3.1 years and dementia developed in
550 participants. The number of parities was associated with the risk of incident dementia
(hazard ratio (HR) = 1.07, 95% confidence interval (CI) = 1.02–1.13). Grand multiparity
(five or more parities) increased the risk of dementia by 30% compared to 1–4 parities
(HR = 1.30, 95% CI = 1.02–1.67). The risk of NAD increased by 12% for every parity
(HR = 1.12, 95% CI = 1.02–1.23) and by 60% for grand multiparity (HR = 1.60, 95% CI =
1.00–2.55), but the risk of AD was not significantly associated with parity.
Conclusions. Grand multiparity is a significant risk factor for dementia in women. This may
have particularly important implications for women in low and middle-income countries
where the fertility rate and prevalence of grand multiparity are high.
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Introduction
Dementia is one of many disorders with gender differences
(Mazure and Swendsen, 2016) and women show a greater preva-
lence of dementia than men (Winblad et al., 2016). However, lon-
gitudinal cohort studies investigating whether the incidence of
dementia differs by gender have shown conflicting results.
Prospective cohort studies in high-income countries (HIC) such
as the USA, the Netherlands and the UK reported no gender dif-
ferences in the incidence of dementia (Bachman et al., 1993;
Paykel et al., 1994; Ruitenberg et al., 2001). On contrary, the
10/66 Dementia Research Group used longitudinal data from
six middle-income countries (MIC), including Cuba, the
Dominican Republic, Venezuela, Peru, Mexico and China and
found that women showed a higher risk of incident dementia
than men even after controlling for age, education and occupa-
tional attainment (Prince et al., 2012). Higher rates of incident
dementia for women in MIC but not HIC may be attributable
to the greater gender differences in education, socialeconomic sta-
tus, lifestyle and health conditions of MIC compared to those of
HIC (Medel-Anonuevo, 1995). Pregnancy and childbirth are the
most distinctive experiences of women that may change hormone
levels, health conditions and lifestyles, and women in MIC have
more childbirths on average than women in HIC (United
Nations, 2019).
Several studies have shown parity to be associated with the
risks for cognitive impairment and dementia. In a case-control
study from Germany, the chances of having at least one child
and the number of children were both greater among 106
women with Alzheimer’s disease (AD) than among 189 women
without dementia (Ptok et al., 2002). In a cross-sectional study
from China on 4796 postmenopausal women, grand multiparous
women (five or more childbirths) showed about 1.3-fold higher
risk of cognitive impairment than women with 1–4 parities (Li
et al., 2016). In a retrospective analysis on the pooled data of
3549 women from two population-based cohort studies in
Korea and Greece, we found that grand multiparous women
showed about 1.7-fold higher risk of AD than women with
one–four parities (Jang et al., 2018). However, the risk of demen-
tia associated with parity reported from these previous studies
employing case-control or cross-sectional designs is subject to
various biases; a selection bias (Tripepi et al., 2010) due to the
shorter life expectancy of grand multiparous women than
women with four parities or less (Hinkula et al., 2006), a
prevalence-incidence bias (Hill, 2003) due to the lower mortality
from dementia in grand multiparous women than women with
four parities or less (Hinkula et al., 2006) and information bias
(Tripepi et al., 2010) due to the greater risk of inaccurate informa-
tion on parity from dementia patients than from cognitively nor-
mal elderly individuals.
In this study, we conducted a pooled analysis on the longitudinal
data from six population-based prospective cohort studies (four
European and two Asian cohorts) to more accurately determine
the effect of parity on the risk of incident dementia in older women.
Methods
Study population
We pooled baseline and follow-up data for community-dwelling
women aged 60 or older from six members of the Cohort
Studies of Memory in an International Consortium (COSMIC)
collaboration (Table 1) (Riedel-Heller et al., 2001; Lobo et al.,
2011; Sachdev et al., 2013; Dardiotis et al., 2014; Ding et al.,
2014; Thorvaldsson et al., 2017; Han et al., 2018). The included
cohorts varied in size from 1016 to 6818 participants. From an
initial sample of 11 300 women, we excluded 1010 who did not
have data on educational level, hypertension, diabetes mellitus
(DM) or parity and 534 diagnosed as having dementia at baseline,
giving a final sample of 9756 women.
Ethics approval
This study was approved by the University of New South Wales
Human Research Ethics Committee (Ref: # HC12446). Each of
the six contributing studies had previously obtained ethics
approval from their respective institutional review boards and
all participants provided informed consent.
Measures
The main outcomes of the present analysis were incident all-cause
dementia, AD and non-Alzheimer dementia (NAD). All studies
provided data on dementia diagnosis, based on DSM-IV criteria
(American Psychiatric Association, 1994) in five studies (Riedel-
Heller et al., 2001; Lobo et al., 2011; Dardiotis et al., 2014; Ding
et al., 2014; Han et al., 2018) and DSM-III-R criteria (American
Psychiatric Association, 1987) in one (Thorvaldsson et al.,
2017). Four studies (Dardiotis et al., 2014; Ding et al., 2014;
Thorvaldsson et al., 2017; Han et al., 2018) diagnosed AD accord-
ing to the NINCDS-ADRDA criteria (McKhann et al., 1984) and
two studies (Riedel-Heller et al., 2001; Lobo et al., 2011) according
to DSM-IV criteria (American Psychiatric Association, 1994). The
main exposure was the number of parities. We assigned parity as
the number of childbirths in four cohorts and as the number of
children in two cohorts. Other data included age, sex, educational
level and the presence of hypertension and DM, which were all
harmonised when necessary. For the presence of hypertension
and DM, we used all available information from a study relevant
to diagnoses (medical history record, self-reported history, use of
relevant medication and measured blood pressure or glucose level
exceeding values indicated by international guidelines).
Analysis
We compared the continuous variables between groups using
one-way analysis of variance with Scheffé’s post hoc analysis
and categorical variables using chi-square tests.
We evaluated the relationship between parity and incident
dementia using Cox proportional hazards regression models
with time-dependent covariates. We used calendar time as the
time axis. The primary outcome was incident dementia and the
risk factor of primary interest was the number of parities.
Participants who developed dementia during follow-up were cen-
sored at the midpoint between their last assessment date when
without dementia and their first assessment date when diagnosed
with dementia. Participants who remained dementia-free during
the follow-up were censored at the most recent assessment date.
We initially analysed the number of parities as a continuous vari-
able and estimated hazard ratios (HRs) and 95% confidence inter-
vals (CIs) with unadjusted and adjusted Cox proportional hazards
regression models. The adjusted model included age, educational
level, hypertension, DM and cohort as covariates. Next, we cate-
gorised parity into three strata – no parity (nulliparity), 1–4 par-
ities and five or more parities (grand multiparity) (Babinszki
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et al., 1999) because both grand multiparity and nulliparity have
been previously associated with the risk of AD (Ptok et al., 2002;
Jang et al., 2018), as well as the risks of medical diseases such as
DM and coronary heart disease (Lawlor, 2003; Nicholson et al.,
2006). We investigated the association of parity with the risks
of AD, and NAD separately. We also analysed the four cohort
studies that provided the number of childbirths and the two
cohort studies that provided the number of children separately.
The KLOSCAD team harmonised and pooled the dataset and
performed the analyses using the Statistical Package for Social
Sciences, v20 (SPSS Inc., Chicago, IL).
Availability of data and materials
The data that support the findings of this study are available from
the corresponding author upon reasonable request
Results
Of 9756 women dementia-free at baseline, 7010 completed one or
more follow-up assessments. The mean follow-up duration was
5.4 ± 3.1 years (Table 2). During the follow-up period, dementia
developed in 550 participants (AD in 380 and NAD in 170).
Compared to participants who remained dementia-free during
follow-up, those who did not complete a follow-up assessment
were older and less educated and those who developed dementia
were older, had more hypertension and DM and gave more child-
births (Table 3).
Parity as continuous
As shown in Table 4, the risk of dementia increased by 7% for
every parity in the adjusted Cox hazard model (HR = 1.07, 95%
CI = 1.02–1.13). The risk of NAD increased by 12% for every par-
ity (HR = 1.12, 95% CI = 1.02–1.23), but the risk of AD was not
significantly associated with the number of parities (HR = 1.05,
95% CI = 0.99–1.11).
Parity as categorical
Compared to the one–four parities group, grand multiparity
increased the risk of dementia by 30% (HR = 1.30, 95%
CI = 1.02–1.67) but nulliparity did not (HR = 0.84, 95% CI =
0.63–1.12). Grand multiparity increased the risk of NAD by
60% (HR = 1.60, 95% CI = 1.00–2.55), but was not associated
with the risk of AD. Nulliparity was not associated with the
risk of either NAD or AD (Table 4).
When we analysed the four cohort studies that provided
the number of childbirths and the two cohort studies that pro-
vided the number of children separately, the number of parities
was associated with the risk of dementia in both groups, although
the association was not statistically significant in the cohorts that
provided the number of children (HR = 1.08, 95% CI = 1.02–1.14
for the cohorts providing the number of childbirths; HR = 1.02,
95% CI = 0.91–1.14 for the cohorts providing the number of
children).
Discussion
We analysed pooled data for 7010 women older women drawn
from six population-based prospective cohort studies, four in
Europe and two in Asia. Our results show the number of parities
to be associated with the risk of incident dementia. Grand multi-
parity increased the risk of dementia by 30%, which is comparable
to the relative risk of dementia due to some well-known risk fac-
tors (1.37 for current/ever smoking (Beydoun et al., 2014), 1.41
for low social participation (Kuiper et al., 2015), 1.33 for midlife
obesity (Albanese et al., 2017) and 1.21 for vitamin D deficiency
(Shen and Ji, 2015)). Although the association of parity and the
risk of dementia in women has been reported by case-control
and cross-sectional studies (Ptok et al., 2002; Jang et al., 2018),
this is the first prospective study to demonstrate an association
between them.
Studies from HIC have reported a similar rate of incident
dementia for men and women (Bachman et al., 1993; Paykel
et al., 1994; Ruitenberg et al., 2001), but those from MIC showed
women to have about 40% higher rates on incident dementia than
men, even after controlling for age, educational level and occupa-
tional attainment (Prince et al., 2012). In the 1960s MIC had a
fertility rate of nearly 6, almost twice that of HIC (United
Nations, 2019). Given this, our results suggest that greater rates
of incident dementia for women than for men in MIC could be
at least partly attributable to high fertility rates and a prevalence
of grand multiparity that is over 20% (Mueller et al., 2013; Jang






H70 Gothenburg, Sweden 2000–2003 White 1016/787/559 74.7 ± 5.4 (70–92) 2.0 ± 1.6 (0–20)
HELIAD Larissa and Marousi,
Greece
2009–2015 White 1814/1074/896 72.1 ± 5.5 (60–93) 2.0 ± 0.8 (0–7)
KLOSCAD Nationwide, South Korea 2011–2012 Asian 6818/3919/3496 70.7 ± 7.2 (60–101) 3.6 ± 1.7 (0–12)
LEILA 75+ Leipzig, Germany 1997–1998 White 1265/964/568 81.2 ± 4.9 (75–99) 1.6 ± 1.3 (0–10)
SAS Shanghai, China 2010–2011 Asian 3141/1873/1772 71.2 ± 8.4 (60–100) 2.0 ± 1.4 (0–9)
ZARADEMP Zaragoza, Spain 1994–1995 White 4638/2683/2465 74.5 ± 9.6 (60–102) 2.4 ± 1.9 (0–12)
H70, Gothenburg H70 Birth Cohort Studies; HELIAD, Hellenic Longitudinal Investigation of Aging and Diet; KLOSCAD, Korean Longitudinal Study on Cognitive Aging and Dementia; LEILA75+,
Leipzig Longitudinal Study of the Aged; SAS, Shanghai Aging Study; ZARADEMP, Zaragoza Dementia Depression Project.
The participants of all studies were randomly sampled.
aNumbers at the baseline assessment.
bMean ± standard deviation (range).
cMean ± standard deviation (range), numbers of children in the H70 and LEILA 75+ and numbers of childbirths in other studies.
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et al., 2018; Solanke, 2019). Grand multiparity is also likely to be a
risk for dementia among women in low-income countries for
which the mean fertility rate was 4.6 in 2017 and where grand
multiparity is still common (United Nations, 2019).
The association between parity and the risk of incident demen-
tia is potentially explained by a number of mechanisms. First, low
high-density lipoprotein (HDL) levels have been associated with
the development of dementia (Rasmussen et al., 2015) and AD
(Reitz et al., 2010), and parous women were reported to have
lower HDL levels than nulliparous women for 3 years after child-
birth (Lewis et al., 1996). This appears to be a persistent effect, as
a significant trend toward lower HDL levels with increasing parity
has been shown in old age (Humphries et al., 2001). Second,
changes in glucose metabolism induced by parity might increase
the risk of dementia. We controlled for DM, which is a known
risk factor of dementia (Ott et al., 1999). However, higher than
average glucose levels in elderly individuals without DM have
also been associated with an increased risk of incident dementia
(Crane et al., 2013). Insulin sensitivity drops to 50% in the
third trimester of pregnancy and grand multiparity is associated
with an increased risk of subsequent clinical insulin resistance
in premenopausal women (Abdelsalam and Elamin, 2017). It
has also been reported that postmenopausal women with four
or more children have higher insulin resistance than nulliparous
Table 2. Design and results of follow-up assessments according to cohorts
Follow-up assessments Numbers with incident dementia
Study Interval (years) Numbers Durationa Completersb All AD NAD
H70 5 2 8.3 ± 2.3 451 72 42 30
HELIAD 3 1 3.0 ± 0.8 528 26 23 3
KLOSCAD 2 3 4.7 ± 1.6 2873 143 113 30
LEILA 75+ 1.5 5 4.5 ± 2.4 568 119 66 53
SAS 5 1 5.0 ± 1.3 900 106 76 30
ZARADEMP 2 2 4.1 ± 1.2 1691 84 60 24
H70, Gothenburg H70 Birth Cohort Studies; HELIAD, Hellenic Longitudinal Investigation of Aging and Diet; KLOSCAD, Korean Longitudinal Study on Cognitive Aging and Dementia; LEILA75+,
Leipzig Longitudinal Study of the Aged; SAS, Shanghai Aging Study; ZARADEMP, Zaragoza Dementia Depression Project; AD, Alzheimer dementia; NAD, non-Alzheimer’s disease.
aMean ± standard deviation.
bNumbers of dementia-free participants at baseline who completed one or more follow-up assessments.
Table 3. Baseline characteristics of the participants
Variable







(N = 550) T or χ2 p Post hoc
Parity (numbers, mean ± S.D.) 2.6 ± 1.7 2.9 ± 2.1 2.5 ± 1.8 16.771 <0.001 A, C < B
Age at baseline (years, mean ± S.D.) 71.2 ± 7.2 79.8 ± 6.2 73.0 ± 9.0 333.922 <0.001 A < C < B
Education (years, mean ± S.D.) 7.9 ± 4.6 7.0 ± 4.6 7.2 ± 4.9 31.956 <0.001 A > B, C
Hypertension (%) 62.0 73.5 62.7 28.571 <0.001 A, C < B
Diabetes mellitus (%) 15.0 20.2 15.4 10.311 0.006 A, C < B
aAnalysis of variance with Scheffe’s posthoc comparison for continuous variables and chi square tests for categorical variables. The level of significance was considered to be P < 0.05.
Table 4. Associations between number of parities and the risk of incident dementia
Model Dementia AD NAD
Numbers of paritya 1.07 (1.02–1.13) 1.05 (0.99–1.11) 1.12 (1.03–1.23)
Parity groupa
1–4 parities Referent Referent Referent
Nulliparity 0.84 (0.63–1.12) 0.87 (0.61–1.24) 0.80 (0.49–1.30)
Grand multiparity 1.30 (1.02–1.67) 1.20 (0.90–1.61) 1.60 (1.00–1.55)
AD, Alzheimer’s disease; NAD, non-Alzheimer’s disease.
Values represent hazard ratio with 95% confidence intervals in the parentheses.
aCox proportional hazards model adjusting for age, educational level, hypertension, diabetes mellitus and cohort.
4 J. B. Bae et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2045796020000876
Downloaded from https://www.cambridge.org/core. Universidad de Zaragoza, on 04 Dec 2020 at 09:28:06, subject to the Cambridge Core terms of use, available at
and primiparous women (Humphries et al., 2001). Third, estro-
gen has a neuroprotective effect (Barha and Galea, 2010;
Inagaki et al., 2010) and low serum bioavailable estradiol has
been associated with the risk of cognitive impairment (Yaffe
et al., 2000). Since parous women were found to have lower levels
of a urinary estradiol metabolite than nulliparous women (Munro
et al., 1991; Barrett et al., 2014), and a lower free estradiol index
reportedly related to the number of parities in postmenopausal
women (Chavez-MacGregor et al., 2008), parity might affect the
risk of dementia by exposing women to reduced serum estrogen
for much of their adult life. Although these influences of multi-
parity may increase the risks of both AD and NAD, our results
suggest that they may more strongly affect the risk of NAD.
Cerebrovascular diseases that are closely associated with lipid
and glucose metabolisms are the most common cause of NAD
(Rizzi et al., 2014) and vascular dementia was the most common
type of incident NAD in the current study.
This study has several strengths compared to previous studies
that were case-control or cross-sectional. First, our dataset consists
of more than 7000 elderly women from six international
population-based cohorts, which is much larger and more represen-
tative than the datasets in previous studies. Second, the probability
of information bias was relatively low. In case-control and cross-
sectional studies, dementia patients with severe cognitive impair-
ment might recall their parity experience incorrectly and it might
introduce information bias. However, the current study obtained
information on parity when the participants were dementia-free.
Lastly, any effect of mortality on the results was also likely to be
smaller. Cross-sectional studies assess participants at a single time
point and dementia patients with a longer survival rate are more
likely to be included than those with a shorter survival rate.
Because grand multiparous women show a decreased risk of mor-
tality from dementia (Hinkula et al., 2006), a prevalence-incidence
bias might affect the results of cross-sectional studies.
This study also has limitations. Changes in lifestyle and beha-
viours induced by parity and socialeconomic status which asso-
ciated with the number of parities could be associated with the
risk of incident dementia and have affected our results, and
while we controlled for educational level, hypertension, DM and
cohort, other confounders might have influenced our outcomes.
Adoption or death of children might have distorted parity infor-
mation because parity data were based on the number of children
in two cohorts and the number of childbirths in four cohorts. In
addition, the effect of parity on the risk of dementia could be
over- or under-estimated because we excluded about one-tenth
of participants whose information on educational level, hyperten-
sion, DM or parity were not available.
In conclusion, grand multiparity is a significant risk factor for
dementia in women. This may have particularly important impli-
cations for women in low and middle-income countries where the
fertility rate and prevalence of grand multiparity are high.
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